Literature DB >> 31101722

Recreational drugs and STI diagnoses among patients attending an STI/HIV reference clinic in Rome, Italy.

Alessandra Latini1, Maria Gabriella Dona'2, Lavinia Alei2, Manuela Colafigli2, Mirko Frasca2, Diego Orsini2, Massimo Giuliani2, Aldo Morrone3, Antonio Cristaudo2, Mauro Zaccarelli4.   

Abstract

BACKGROUND: An observational study was conducted to assess recreational drug use in association with recent STIs among clients of an STI/HIV reference centre in Rome, Italy.
METHODS: Attendees self-compiled a questionnaire concerning sexual behaviours and drug use, including the nine drugs used for sex (amphetamines, poppers, cocaine, ketamine, erectile dysfunction agent (EDA), steroids and the three chemsex drugs, ie, chems: γ-hydroxybutyric acid/γ-butyrolactone, crystal and Mcat).
RESULTS: Overall, 703 patients participated, with men who have sex with men (MSM) accounting for 50.4% of the total and 73.2% of HIV-positive patients. Apart from condylomatosis, whose prevalence was higher among females (38.8%) and non-MSM (45.8%) than MSM (14.4%), STIs were more frequent among MSM, particularly syphilis (14.1%), gonorrhoea (4.8%), urethritis (3.4%) and hepatitis A (6.5%). Recreational drug use was significantly more frequent among MSM (39.8% vs 17.6% in females and 22.7% in non-MSM). A total of 26.3% of MSM used at least one of the nine drugs and 5.1% at least one of the three chems. Cocaine (13.3%) and poppers (13.0%) were the most used sex drugs in MSM.The use of any of the nine drugs was associated with being MSM (adjusted OR (AOR): 1.94, 95% CI 1.05 to 3.58), sex with partner contacted online (1.99, 95% CI 1.14 to 3.45), group sex (4.08, 95% CI 2.40 to 6.93) and STI in the last year (1.65, 95% CI 1.05 to 2.61). Use of any of the nine chems among MSM was associated with condomless sex (2.24, 95% CI 1.21 to 4.14), group sex (2.08, 95% CI 1.01 to 4.31) and STI diagnosis in the last year (4.08, 95% CI 2.32 to 7.19).
CONCLUSIONS: Our data suggest that recreational drug use is quite common among MSM in Italy. No evidence of association with STI was found among non-MSM and females, where only cannabis and cocaine use was reported. The use of chems is still limited, but cocaine, poppers and EDA are widely used among MSM. Recreational drug use appears associated with high-risk sexual behaviours and a higher risk of STI. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  gay men; infectious diseases; sexual behaviour; substance misuse

Mesh:

Substances:

Year:  2019        PMID: 31101722     DOI: 10.1136/sextrans-2019-054043

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  3 in total

1.  Socio-Demographic Characteristics and Sexual Behavioral Factors of Patients with Sexually Transmitted Infections Attending a Hospital in Southern Italy.

Authors:  Teresa Fasciana; Giuseppina Capra; Paola Di Carlo; Cinzia Calà; Marco Vella; Giuseppe Pistone; Claudia Colomba; Anna Giammanco
Journal:  Int J Environ Res Public Health       Date:  2021-04-28       Impact factor: 3.390

Review 2.  Collateral Damage: A Narrative Review on Epidemics of Substance Use Disorders and Their Relationships to Sexually Transmitted Infections in the United States.

Authors:  Steffanie Ann Strathdee; Claire C Bristow; Tommi Gaines; Steven Shoptaw
Journal:  Sex Transm Dis       Date:  2021-07-01       Impact factor: 3.868

3.  Chems4EU: chemsex use and its impacts across four European countries in HIV-positive men who have sex with men attending HIV services.

Authors:  Gary G Whitlock; Konstantinos Protopapas; Jose I Bernardino; Arkaitz Imaz; Adrian Curran; Christof Stingone; Sivapatham Shivasankar; Sarah Edwards; Sophie Herbert; Konstantinos Thomas; Rafael Mican; Paula Prieto; Jorge Nestor Garcia; Massimo Andreoni; Samantha Hill; Hajra Okhai; David Stuart; Adam Bourne; Katie Conway
Journal:  HIV Med       Date:  2021-08-25       Impact factor: 3.094

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.